BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20739953)

  • 1. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias.
    Morisot S; Wayne AS; Bohana-Kashtan O; Kaplan IM; Gocke CD; Hildreth R; Stetler-Stevenson M; Walker RL; Davis S; Meltzer PS; Wheelan SJ; Brown P; Jones RJ; Shultz LD; Civin CI
    Leukemia; 2010 Nov; 24(11):1859-66. PubMed ID: 20739953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse.
    Lock RB; Liem N; Farnsworth ML; Milross CG; Xue C; Tajbakhsh M; Haber M; Norris MD; Marshall GM; Rice AM
    Blood; 2002 Jun; 99(11):4100-8. PubMed ID: 12010813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
    Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
    Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
    Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hoechst 33342 Staining Identifies the Progenitor Side Population in NOD.Cg-PrkdcscidIL2rgtmWjl/Sz Mice Harboring Pediatric Leukemias.
    Andre MC; Witte KE; Hoerrmann RA; Schmitt A; Handgretinger R; Ebinger M
    In Vivo; 2015; 29(6):661-9. PubMed ID: 26546522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
    Cheung AM; Fung TK; Fan AK; Wan TS; Chow HC; Leung JC; Chan LY; Kwong YL; Liang R; Leung AY
    Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia.
    Cox CV; Martin HM; Kearns PR; Virgo P; Evely RS; Blair A
    Blood; 2007 Jan; 109(2):674-82. PubMed ID: 17003368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
    Williams MT; Yousafzai YM; Elder A; Rehe K; Bomken S; Frishman-Levy L; Tavor S; Sinclair P; Dormon K; Masic D; Perry T; Weston VJ; Kearns P; Blair H; Russell LJ; Heidenreich O; Irving JA; Izraeli S; Vormoor J; Graham GJ; Halsey C
    Blood; 2016 Apr; 127(16):1998-2006. PubMed ID: 26869395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Bhadri VA; Cowley MJ; Kaplan W; Trahair TN; Lock RB
    BMC Genomics; 2011 Nov; 12():565. PubMed ID: 22093874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.
    Bachmann PS; Gorman R; Mackenzie KL; Lutze-Mann L; Lock RB
    Blood; 2005 Mar; 105(6):2519-26. PubMed ID: 15572593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.
    Lühl NC; Zirngibl F; Dorneburg C; Wei J; Dahlhaus M; Barth TF; Meyer LH; Queudeville M; Eckhoff S; Debatin KM; Beltinger C
    Haematologica; 2014 Jun; 99(6):1050-61. PubMed ID: 24700491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP; Shao L; Billman GF; Yu J
    Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
    Diamanti P; Cox CV; Moppett JP; Blair A
    Blood; 2013 Feb; 121(8):1384-93. PubMed ID: 23264600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculation.
    Wang N; Huang L; Wang D; Wang J; Jiang L; Zhou K; Yang Y; Xu D; Zhou J
    Cancer Biol Ther; 2012 Oct; 13(12):1158-64. PubMed ID: 22892848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD133 on leukemia-initiating cells in childhood ALL.
    Cox CV; Diamanti P; Evely RS; Kearns PR; Blair A
    Blood; 2009 Apr; 113(14):3287-96. PubMed ID: 19147788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction.
    Rajakumar SA; Papp E; Lee KK; Grandal I; Merico D; Liu CC; Allo B; Zhang L; Grynpas MD; Minden MD; Hitzler JK; Guidos CJ; Danska JS
    Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice.
    Tillman H; Janke LJ; Funk A; Vogel P; Rehg JE
    Vet Pathol; 2020 Jan; 57(1):160-171. PubMed ID: 31736441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.